Program Goals

The purpose of this educational activity is to review laboratory diagnostic techniques in virology. Emphasis will be placed on advancements in automated nucleic acid detection techniques, real time methodology, and new assays being developed for clinically important viruses.

Target Audience

Medical laboratory, virology, or molecular technologists/scientists, pathologists, laboratory supervisors or directors and other health care professionals with an interest in the latest developments in clinical and diagnostic virology.

Educational Objectives

Upon completion of this activity, participants should be able to:

1. Review commonly used current and new testing technologies for respiratory viruses and describe their advantages and disadvantages in different clinical settings.
2. Discuss practical issues in implementing respiratory panel tests.
3. List and discuss the benefits of respiratory viral panel testing in patient management and formulate recommendations on testing strategies in specific clinical settings.

Faculty

Dr. Preeti Pancholi, PhD D(ABMM)
Director; Clinical Microbiology
Associate Professor, Clinical Pathology
The Ohio State University Medical Center

Disclosure of Conflicts of Interest

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosure Summary

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. adhere to established standards regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known below.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.^® accredited activity: 

How to Obtain P.A.C.E.^® Credit

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.^® approved continuing education. To receive credit, the course must be completed by July 28, 2010.

Should you have any P.A.C.E.^® questions regarding this activity, please contact:

ASCLS P.A.C.E.^®
6701 Democracy Blvd., Suite 300
Bethesda, MD 20817-1574
Ph: 301-657-2768
Fx: 301-657-2909
http://www.ascls.org/

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Clinical Laboratory Science (ASCLS) and Dane Garvin Ltd. (DGL) do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. protect the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Additionally, personal information will not be released to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.

"Evolving Respiratory Viral Testing and Impact on Patient Management"

System Requirements

For technical difficulties, please consult our Technical Instructions.

Copyright

Copyright © July 28, 2010.  Dane Garvin, Ltd.   All Rights Reserved.   Permission for accreditation is granted to the American Society for Clinical Laboratory Science.